Eli Lilly and Company (NYSE: LLY), a United States-based pharmaceutical company, announced on Monday its dividend for the third quarter of 2023.

The company has declared dividend of USD1.13 per share on outstanding common stock.

The dividend will be paid to shareholders of record at 15 August 2023 on 8 September 2023.

Eli Lilly has a growing portfolio of medicines that includes treatments in the areas of bone muscle joint, cancer, cardiovascular, diabetes, endocrine, immunology, neurodegeneration, neuroscience, and pain.